OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles.

So here is a new title

This one has got the charts at the top again & has a link to the old one.
http://www.moneyam.com/InvestorsRoom/posts.php?tid=5021

I almost felt the directors clubbed together today just to try and bolster the sp

Director-purchases ( en-masse), are caused by legal requirements such that Dirs cannot buy during a "closed period" - that really happens quite often, like when results are about to be released, expectation of a big order or bad news anticipated when one of their customers nis in difficulty. OXB isn't likley to have some of these, but there are enough places where "News" might prevent Director dealing, within say 2 months of any News that might lead to a sp movement.

As I posted yesterday - the amounts are not all that spectacular; but nevertheless welcome. . . .at least they aren't Selling - that's some comfort, eh?

There were four sells of 50k, resulting in a small drop in sp. today.

EDIT (6Oct08)-12.5% fall - yet buys are 2x Sells . . . . never understood this game.
EDIT (13Oct08)-New Director given 150k-worth of "incentive"...Grr.
EDIT (30Oct08)- Shares says "sell", now 5p and slipping despite market-upturn.

Reasonably good New-Year News - US-Patent dispute has been thrown out, although as I read the RNS, seems the complainer can register another one within 14-days - but why would they?
Begs the Q why they did in the first place, or were they hopeful of some out-of Court settlement - all very odd.
Virtually zero effect on Sp, so I guess the strong bad-vibes on Trovax prevail and won't impress investors at least until there is some good data from the Trial, as it ramps down. It is very disapointing to see this investment fall to such low-levels as it was 25p(June08) having been somewhat higher.
DYOR

I too am a hangon with much faith in this one for a variety of reasons and rather like PDX (another British Company) it could well be a tenbagger.

Oakapples, what's yr take on PDX ? - as I recall it's a steam pump, what used to be called an injector ( Railway locos use them), so I don't see that 1)it's novel and 2) needed....although I know many punters believed it worth paying 5 for 1p stock. Do you see special virtue in their business?...for it occurs to me that they should be selling like hot-cakes to the "specialist" industries...yet sales are miserably tiny....
Mind-you my belief in OXB has been severly dented, with Execs in hibernation, so it seems!

Expect a BIG movement in the next 7 days - back to July levels.

?? Why ??

you're sounding like me!!

Why?

RESULTS DATE: 12 MARCH 2009

Oxford, UK - 25 February 2009: Oxford BioMedica (LSE: OXB), a leading gene therapy company, announces today that it will be releasing its preliminary results for the twelve months ended 31 December 2008 on Thursday, 12 March 2009.



Analyst meeting: An analyst briefing will be held at 09:30 am on Thursday, 12 March 2009 at the offices of Buchanan Communications, 45 Moorfields, London EC2Y 9AE.



Web cast: Simultaneously to the analyst briefing at 09:30 am, there will be a live audio web cast of the presentation. To connect to the web cast facility, please go to the Company's website: http://www.oxfordbiomedica.co.uk/ approximately 10 minutes (09:20 am) before the start of the briefing. This will also be available for replay shortly after the presentation.

Nice rise of 25%. Can't see any reason why but seems to follow the trend of some stocks atm. Perhaps MM's are starting to mark some of these up at last.

45% is a nice mark-up eh. I find similar movement with PDX and GFM which have been dormant for too long.

see FTSE thread

Low volumes, MM playing games, don't get locked in!

FWIW, I think MM's are marking up stocks whenever there is any demand, partly to get more for the stock they may hold from earlier, but more-likely to get some folks to sell ( to satisfy the Buyers).
Thus there is no need to panic-buy - unless you believe this stock is really worth much more - my av. is about 35p, so some way to go, yet.

Some good news for OXB this morning:

OXB - new collaboration agreement with Sanofi-Aventis

'The initial payment from Sanofi-Aventis significantly strengthens Oxford BioMedica's financial resources. As a result, with pro forma net cash as at 31 December 2008 of approximately 51 million, the Directors estimate that current cash is sufficient to support the Company's operations into 2012.'

heres hoping it helps drive the stock up - lets see what the outcome of the anylysts meeting is?

Sure it's good News, but it only confirms a belief - it is not in itself a profit-stream . . . althjough maybe closer than anything else the Market reacts to.
+I note that Pendragon is up 44% on new financing - sure that means "certainty", but you can bet it will cost and there may be strings . . . . (I don't hold [PEND], yet).

EDIT (010609)-Up to 10p mid on RNS that Trovax is getting good reveiws.

some good news again for trovax at last

Looks like this is really starting to move up now - so glad I bought back and seeing a profit!

OXB recently presented at a major international conference: "In all trials, TroVax was well tolerated with no serious adverse events..."